Giulia Sorgentoni
Macerata, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1α).
Journal: Biochemistry and biophysics reports
Published: March 23, 2025
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 05, 2024
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Journal: Minerva urology and nephrology
Published: August 02, 2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Journal: Targeted oncology
Published: May 22, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: May 04, 2023
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Journal: European urology oncology
Published: February 17, 2023
Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis.
Journal: Expert opinion on drug metabolism & toxicology
Published: April 29, 2022
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 19, 2021
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents.
Journal: Anti-cancer drugs
Published: August 13, 2021
Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.
Journal: Translational andrology and urology
Published: April 14, 2021
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease.
Journal: Frontiers in aging neuroscience
Published: December 28, 2020
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
Journal: Diagnostics (Basel, Switzerland)
Published: December 22, 2020
Last Updated: 09/26/2026